Onco-Innovations closes $400,000 private placement

Onco-Innovations Limited (CBOE CA: ONCO) closed a non-brokered private placement raising $400,000 in gross proceeds, the company announced August 13.

The placement consisted of 243,903 units priced at $1.64 each. Each unit includes one common share and one warrant exercisable at $2.05 per share for 36 months until August 13, 2028.

The company will use proceeds for general corporate and working capital purposes, including operational and research and development objectives. Onco-Innovations also issued 2,439 administrative shares to a third party for services related to the placement.

All securities issued are subject to a statutory hold period expiring December 14, 2025, according to applicable securities laws.

Onco-Innovations trades on multiple exchanges including Frankfurt (W1H) and OTCQB (ONNVF). The Vancouver-based company focuses on cancer research and treatment, holding an exclusive worldwide license to patented technology targeting solid tumors.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• Macquarie sees diverging EV trends in US, Europe and China
• KBAT Group files for 6.25M share IPO at $4-$5/sh